prophylactic effect of zinc sulphate on hyperbilirubinemia in premature very low birth weight neonates: a randomized clinical trial

Authors

ashraf mohammadzadeh professor of neonatology, neonatal research center, imam reza hospital, faculty of medicine, mashhad university of medical sciences, mashhad, iran.

ahmad shah farhat assistant professor of neonatology. neonatal research center, imam reza hospital, faculty of medicine, mashhad university of medical sciences, mashhad, iran

abbas alizadeh kaseb fellowship of neonatology, neonatal research center, imam reza hospital, faculty of medicine, mashhad university of medical sciences, mashhad, iran

fatemeh khorakian assistant professor of pediatric dentistry, dental research center, faculty of dentistry, mashhad university of medical sciences, mashhad, iran

abstract

introduction: one of the common problems in neonatal period is jaundice that occurs in the first week of birth in 60% of term and 80% of preterm neonates. in preterm newborn hyperbilirubinaemia is higher, persistent, longer, and more likely to be associated with neurological injury than term neonates. the purpose of this study was to determine prophylactic effect of zinc sulphate on hyperbilirubinemia in premature very low birth weight neonates. method and material: sixty newborns who admitted in our nicu which had inclusion criteria were eligible in this trial. included neonates were randomly placed in two groups (case and control) and before intervention the total serum bilirubin (tsb) was measured at second day. the participant received either 20 mg of zinc sulfate or placebo through ng-tube divided in two doses till day seven of age. then total and indirect bilirubin was measured at 3ed, 5th and 7th day of life. if any of newborns in duration of hospitalization develop clinical jaundice, after assessment of bilirubin, need for phototherapy was evaluated based on phototherapy and exchange schedule as described by the american academy of pediatrics guidelines. the termination point of phototherapy was defined as a bilirubin level less than 50 percent of starting point. after gathering data, they were analyzed using spss software (version 11.5) and t-test, chi-square and repeated measurement tests. results: seventy eight patients enrolled in this trial that 18 cases were excluded and the remaining cases divided into two equal groups (n=30 in each group). demographic condition was similar in two groups. there were no different between two groups in decreasing total serum bilirubin and duration of phototherapy. conclusion: this study showed that zinc sulfate has no preventing effective in hyperbilirubinemia in preterm very low birth weight neonates. it has also no effect on duration of phototherapy.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Prophylactic effect of zinc sulphate on hyperbilirubinemia in premature very low birth weight neonates: a randomized clinical trial

Introduction: One of the common problems in neonatal period is jaundice that occurs in the first week of birth in 60% of term and 80% of preterm neonates. In preterm newborn hyperbilirubinaemia is higher, persistent, longer, and more likely to be associated with neurological injury than term neonates. The purpose of this study was to determine Prophylactic effect of zinc sulphate on hyperbiliru...

full text

Prophylactic oral probiotic on prevention of feeding intolerance in Very Low Birth Weight (VLBW) neonates: Randomized Clinical Trial

Background: Feeding intolerance is prevalent in very low birth weight (VLBW) neonates and is a barrier for better and faster growth in these neonates. Some studies have supported the administration of oral probiotic to decrease feeding intolerance. The aim of this study was to evaluate the effect of probiotic on feeding intolerance in VLBW neonates. Methods: This randomized clinical trial st...

full text

prophylactic oral probiotic on prevention of feeding intolerance in very low birth weight (vlbw) neonates: randomized clinical trial

background: feeding intolerance is prevalent in very low birth weight (vlbw) neonates and is a barrier for better and faster growth in these neonates. some studies have supported the administration of oral probiotic to decrease feeding intolerance. the aim of this study was to evaluate the effect of probiotic on feeding intolerance in vlbw neonates. methods: this randomized clinical trial study...

full text

Effects of oral zinc sulfate on hyperbilirubinemia in low-birth-weight neonates

Background: Hyperbilirubinemia is one of the most common and persistent problems encountered in preterm newborns. This condition in preterm infant is more likely to be associated with neurological damage rather than terms. So far, no major studies have precisely assessed the effects of zinc sulfate on hyperbilirubinemia in low-birth-weight (LBW) neonates. Therefore, in this study, we aimed to e...

full text

Clinical Effects of Carnitin Supplementation on Hypoglycemia, Apnea and Sepsis in Very Low Birth Weight Neonates

Background Systemic carnitine deficiency may present with apnea, hypotonia, and poor growth. Premature infants often manifest these symptoms and are at risk of developing carnitine deficiency because of immaturity of the biosynthetic pathway, lack of sufficient predelivery transplacental transport, and lack of sufficient exogenous supplementation. Objective This study was undertaken to examine ...

full text

Metabolic Bone Disease in Very Low-Birth-Weight Neonates

Background: Metabolic bone diseases (MBD), including rickets and osteopenia, are important neonatal complications among preterm infants. This study aimed to determine the prevalence and risk factors of MBD in neonates with very low birth weight (VLBW). Methods: This prospective study was conducted on VLBW infants from January 2012 to July 2013. Inclusion criteria were birth weight of ≤1500 g a...

full text

My Resources

Save resource for easier access later


Journal title:
iranian journal of neonatology

جلد ۵، شماره ۴، صفحات ۶-۱۰

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023